AUTHOR=Glenn Omolara-Chinue , Tagliafierro Lidia , Beach Thomas G. , Woltjer Randy L. , Chiba-Falek Ornit 

TITLE=Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168

JOURNAL=Frontiers in Genetics

VOLUME=8

YEAR=2017

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2017.00133

DOI=10.3389/fgene.2017.00133

ISSN=1664-8021

ABSTRACT=<p>The <italic>SNCA</italic> intronic single nucleotide polymorphism (SNP), rs356168, has been associated with Parkinson’s disease (PD) in large genome wide association studies (GWAS). Recently, the PD-risk allele, rs356168-G was shown to increase <italic>SNCA</italic>-mRNA expression using genome edited human induced pluripotent stem cells (iPSC)-derived neurons. In this study, as means of validation, we tested the effect of rs356168 on total <italic>SNCA</italic>-mRNA levels using brain tissues, temporal and frontal cortex, from healthy control donors. Carriers of the rs356168-G allele demonstrated a borderline significant decrease of <italic>SNCA</italic>-mRNA levels in temporal brain tissues (<italic>p</italic> = 0.02) compared to individuals homozygous for the ‘A’ allele. Similar trend, but weak, was observed in the analysis of frontal cortex samples, however, this analysis did not reach statistical significance. These results conflict with the recently reported effect of <italic>SNCA</italic> SNP rs356168 described above. Our study conveys the need to carefully interpret the precise molecular mechanism by which rs356168, or another tightly linked variant, affects the regulation of <italic>SNCA</italic> expression. The regulatory mechanisms that contribute to the observed associations between PD and the <italic>SNCA</italic>-3′ linkage disequilibrium region warrant further investigations.</p>